1. Home
  2. IMNN vs SSM Comparison

IMNN vs SSM Comparison

Compare IMNN & SSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$2.67

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

SSM

Sono Group N.V. Ordinary Shares

N/A

Current Price

$4.25

Market Cap

10.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNN
SSM
Founded
1982
2016
Country
United States
Germany
Employees
N/A
43
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
10.6M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
IMNN
SSM
Price
$2.67
$4.25
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
32.8K
90.2K
Earning Date
05-14-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1,462,987.20
Revenue Next Year
N/A
$48.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$4.03
52 Week High
$9.32
$10.54

Technical Indicators

Market Signals
Indicator
IMNN
SSM
Relative Strength Index (RSI) 34.66 28.26
Support Level $2.59 N/A
Resistance Level $3.24 $7.60
Average True Range (ATR) 0.17 1.14
MACD -0.01 -0.21
Stochastic Oscillator 8.11 6.12

Price Performance

Historical Comparison
IMNN
SSM

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About SSM Sono Group N.V. Ordinary Shares

Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and Services includes Complete Solar Solutions, Solar Charge Controllers, Solar Modules, and Data Services and Engineering Services.

Share on Social Networks: